Utilization of sacubitril/valsartan in real-world settings

被引：0
|
作者：
Eworuke, Efe [1 ]
Menzin, Talia [2 ]
Kolonoski, Joy [2 ]
Huang, Ting-Ying [2 ]
机构：
[1] US FDA, Silver Spring, MD USA
[2] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
3825
引用
收藏
页码：144 / 145
页数：2
相关论文
共 50 条
  • [41] Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction
    Polito, Maria Vincenza
    Silverio, Angelo
    Rispoli, Antonella
    Vitulano, Gennaro
    D'Auria, Federica
    De Angelis, Elena
    Loria, Francesco
    Gigantino, Alberto
    Bonadies, Domenico
    Citro, Rodolfo
    Carrizzo, Albino
    Galasso, Gennaro
    Iaccarino, Guido
    Vecchione, Carmine
    Ciccarelli, Michele
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [42] Sacubitril/valsartan improves cardiac function in Chinese patients with heart failure: a real-world study
    Chen, Wenwen
    Liu, Yanlin
    Li, Yuanmin
    Dang, Heqin
    [J]. ESC HEART FAILURE, 2021, 8 (05): : 3783 - 3790
  • [43] PHARMACOUTILIZATION AND ADHERENCE TO SACUBITRIL/VALSARTAN IN REAL-WORLD: THE REAL.IT STUDY IN HEART FAILURE WITH REDUCED EJECTION FRACTION
    Iacoviello, M.
    Di Gesaro, G.
    Sarullo, F.
    Miani, D.
    Driussi, M.
    Correale, M.
    Bilato, C.
    Passantino, A.
    Carluccio, E.
    Villani, A.
    Esposti, L. Degli
    D'Agostino, C.
    Peruzzi, E.
    Poli, S.
    Di Lenarda, A.
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [44] Sacubitril/Valsartan in real world heart failure proctice in Asia
    Chu, P. H.
    Hsia, F. C.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 412 - 412
  • [45] Sacubitril-valsartan prescription during heart failure hospitalization: real-world initial experience.
    Morillas Climent, H.
    Galcera Jornet, E.
    Alania Torres, E.
    Seller Moya, J.
    Vicedo Lopez, A.
    Rodriguez Pichardo, Y.
    Larumbe Rodriguez, A.
    Valle Munoz, A.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 309 - 309
  • [46] Is Sacubitril/Valsartan Under-Prescribed in The United States? A Real-World Insight from The Explorys Registry
    Khayata, Mohamed
    Al Al-Kindi, Sadeer
    Njoroge, Linda
    Oliveira, Guilherme H.
    [J]. JOURNAL OF CARDIAC FAILURE, 2018, 24 (08) : S13 - S13
  • [47] Sacubitril/valsartan vs. angiotensin receptor inhibition in heart failure: a real-world study in Taiwan
    Chang, Po-Cheng
    Wang, Chun-Li
    Hsiao, Fu-Chih
    Wen, Ming-Shien
    Huang, Chien-Ying
    Chou, Chung-Chuan
    Chu, Pao-Hsien
    [J]. ESC HEART FAILURE, 2020, 7 (05): : 3003 - 3012
  • [48] Five Years of Sacubitril/Valsartan-a Safety Analysis of Randomized Clinical Trials and Real-World Pharmacovigilance
    Kim, Yee Soo
    Brar, Simerjeet
    D'Albo, Natalie
    Dey, Amit
    Shah, Sachin
    Ganatra, Sarju
    Dani, Sourbha S.
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (05) : 915 - 924
  • [49] Effectiveness and safety of sacubitril/valsartan in patients with stage 4 chronic kidney disease in a real-world population
    Joana Brito, J.
    Agostinho, J.
    Pereira, S.
    Rodrigues, T.
    Nunes-Ferreira, A.
    Silverio-Antonio, P.
    Rigueira, J.
    Silva, D.
    Pinto, Fausto
    Brito, D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 134 - 134
  • [50] Effects of sacubitril/valsartan on real-world patients with heart failure due to non-ischemic cardiomyopathy
    Hsu, C-Y
    Lin, Y-C
    Huang, C-Y
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 407 - 408
12345